New blood test could save lives in liver failure bleeding emergencies
NCT ID NCT05124041
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a special blood test (ROTEM) can better guide blood transfusions in people with acute-on-chronic liver failure who are bleeding from enlarged veins. 262 participants were randomly assigned to receive transfusions based on either the new test or standard lab tests. The goal was to see if the new approach reduces bleeding, transfusion side effects, and blood clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Postgraduate Institute of Medical Education and Research
Chandigarh, Choose Any State/Province, 160012, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental injection aims to combat Life-Threatening liver failure
- Blood transfusion strategy could be refined for liver patients
- Decade-Long study aims to unlock liver disease risks in HIV-Hepatitis b patients
- Could stem cells offer a lifeline for sudden liver failure?
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New study tracks blood sugar in liver disease patients on common drug